Enter
Enter is a Brazilian AI platform that runs high-volume litigation for corporate legal departments.
Medrecords AI
Cited chronologies and expert reports in hours, not days. Priced per unique page. No seat fees, no subscriptions. First case is free on us.
Enter vs Medrecords AI
At a Glance
| Detail | Enter | Medrecords AI |
|---|---|---|
| Category | eDiscovery | eDiscovery |
| Total raised | $135M | Not disclosed |
| Rounds tracked | 2 | Not disclosed |
| Latest round | Series B, $100M · May 2026 | Not disclosed |
| Last valuation | $1.2B | Not disclosed |
| Lead investors | Founders Fund, Sequoia Capital | Not disclosed |
| Built for | In-house teams | Not disclosed |
| Headquarters | Brazil | US |
Funding, Side by Side
Enter rounds
- May 2026Series B$100M
- Sep 2025Series A$35M
Medrecords AI rounds
No public rounds tracked yet.
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Enter or Medrecords AI?
- Enter has raised $135M in disclosed funding, compared with no disclosed amount for Medrecords AI.
- What is Enter best for?
- Enter is a Brazilian AI platform that runs high-volume litigation for corporate legal departments.
- What is Medrecords AI best for?
- Cited chronologies and expert reports in hours, not days. Priced per unique page. No seat fees, no subscriptions. First case is free on us.
Source: Legal Tech Circle funding data, from public announcements. Updated November 12, 2026.